Androgenetic Alopecia

Androgenetic Alopecia, commonly known as male or female pattern hair loss, is a common progressive condition characterized by gradual thinning of hair following a predictable pattern influenced by genetics and hormones. In men, it typically presents as a receding hairline and thinning at the crown, while women more often experience diffuse thinning over the top of the scalp with a preserved hairline. The condition results from hair follicles becoming increasingly sensitive to androgens, causing them to shrink and produce progressively finer, shorter hairs over time. It is the most common cause of hair loss in both sexes.

The most common symptoms include: Gradual thinning of hair on the scalp; receding hairline in men; widening part line in women; miniaturization of hair strands becoming finer and shorter. Early recognition is key to prompt diagnosis and effective treatment.

No, Androgenetic Alopecia is not contagious. It cannot spread through casual contact. However, certain risk factors and genetic predispositions may increase susceptibility.

Treatment options include: Topical minoxidil is a widely used first-line treatment to stimulate hair growth; while oral finasteride is commonly used in men to block the hormone responsible for follicle shrinkage. Hair transplant surgery offers a more permanent solution for advanced hair loss; and newer treatments such as platelet-rich plasma therapy are increasingly used to support regrowth.. Treatment should always be guided by a qualified Dermatology specialist. Do not self-medicate.

While Androgenetic Alopecia cannot always be fully prevented, several measures can reduce risk: No guaranteed prevention due to genetic basis; but early treatment to slow progression; avoiding harsh hair treatments and excessive heat styling.

Consult a Dermatology specialist if symptoms persist for more than a few days, worsen despite home care, or significantly affect your daily activities. Early diagnosis leads to better outcomes.